glp-1 agonists in development Receptor Agonist Market Size & Analysis, 2026-2033 Mapping the effectiveness and risks
Description
Brand-name pricing for tirzepatide and semaglutide will face downward pressure as more options reach market
Zepbound, KwikPen, and LillyDirect are registered trademarks, and Foundayo is a trademark of Eli Lilly and Company
Related studies have demonstrated that GLP-1R activation upregulates in situ expression of fibroblast growth factor-7 (FGF7) in intestinal tumor cells, promoting tumor progression and inducing intestinal hyperplasia
3.7 Cardiovascular effects In a GWAS, the genetic GIP receptor variant, E354Q, and the risk of cardiovascular diseases are nominally associated (112), and also, carriers of E354Q have been associated with lower risk of coronary artery disease (113)
Lajthia E, Bucheit JD, Nadpara PA, Dixon DL, Caldas LM, Murchie M, et al
Elashoff, M
